Antagonism of type I interferon by flaviviruses

https://doi.org/10.1016/j.bbrc.2017.05.146Get rights and content

Highlights

  • Flaviviruses are arthropod-borne viruses, many of which represent an expanding threat to public health worldwide.

  • Type I Interferons are key innate immune regulators for antiviral defense.

  • Flaviviruses have evolved multiple strategies to overcome innate immune detection and ensure viral replication and spread.

  • This evolutionary struggle for survival results in a balance for coexistence of both hosts and viruses.

Abstract

The prompt and tightly controlled induction of type I interferon is a central event of the immune defense against viral infection. Flaviviruses comprise a large family of arthropod-borne positive-stranded RNA viruses, many of which represent a serious threat to global human health due to their high rates of morbidity and mortality. All flaviviruses studied so far have been shown to counteract the host's immune response to establish a productive infection and facilitate viral spread. Here, we review the current knowledge on the main strategies that human pathogenic flaviviruses utilize to escape both type I IFN induction and effector pathways. A better understanding of the specific mechanisms by which flaviviruses activate and evade innate immune responses is critical for the development of better therapeutics and vaccines.

Introduction

“It takes all the running you can do, to keep in the same place” – Through the looking Glass, by Lewis Carroll.

Leigh Van Valen, the founder of the “Red Queen Hypothesis”, used the Red Queen as a metaphor of the evolutionary arms races that are common to several genetic conflicts including host-pathogen interactions [1]. As a consequence of the selection pressure, throughout evolution eukaryotes developed sophisticated mechanisms to recognize and contain viral infections, and viruses in turn adapted multiple tricks to disrupt host defense pathways and hijack host processes to their advantage [2], [3], [4].

Type I interferons (IFNs) are a family of cytokines with essential roles in the defense of mammalian cells against viral infection and in the activation of immune responses. IFN was originally discovered more than 50 years ago by Isaacs and Lindenmann as a soluble factor produced by influenza virus-infected cells, and able to suppress subsequent infection with homologous or heterologous viruses in vitro [5], [6], [7]. Since then, remarkable advances have been made in our understanding of how type I IFN is produced in response to different stimuli, and how IFN signaling reprograms cellular biology to establish an effective antiviral role, and to enhance adaptive immune responses. In addition, several viral innate immune evasion strategies have been uncovered, which highlights the importance of the IFN signaling pathway in controlling viral replication and pathogenesis. This is of particular importance, since a better understanding of the molecular mechanisms by which different viruses manipulate and subvert the host immune response may contribute to the development of new live attenuated vaccines and antiviral drugs.

Flaviviruses are arthropod-borne viruses with a global impact on public health. They include important human pathogens such as Dengue (DENV), Japanese encephalitis (JEV), West Nile (WNV), Yellow Fever (YFV), Zika (ZIKV), and Tick-borne encephalitis (TBEV) viruses, many of which are resurging and spreading to new environments [8], [9]. Typically, these viruses contain a 10–11 kb positive-sense, single-stranded RNA genome that encodes a single polyprotein. After translation, the viral polyprotein localizes at the endoplasmic reticulum (ER) membrane where it is cleaved by viral and host proteases to generate three structural (C, prM and E), and seven non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) proteins. The structural proteins form the virion and are involved in viral attachment, fusion, and assembly. The non-structural proteins regulate viral transcription and replication and are required to modulate host antiviral responses. Interestingly, like all studied positive-strand RNA viruses, flaviviruses hijack cytoplasmic membranes in order to build functional sites for protein translation, processing and RNA replication [10], [11], [12], [13], [14], [15]. These sites, generally defined as replication compartments (RCs), are required to efficiently coordinate different steps of the viral life cycle and to shield replicating RNA from innate immunity surveillance [16], [17].

In this review, we provide an overview of the different strategies used by human pathogenic flaviviruses to antagonize type I IFN responses in order to establish a productive infection. We discuss both the passive and active mechanisms exploited by flaviviruses to prevent innate immune recognition by cytoplasmic pattern recognition receptors (PRRs) and subsequent IFN induction. In this regard, a particular focus is given to the recently described mechanisms of inhibition of the RIG-I like receptors (RLRs) and cyclic GMP-AMP (cGAS) - stimulator of the interferon gene protein (STING) pathways by DENV. In addition, we summarize several studies that, in the last 10 years, have contributed elucidating the mechanisms by which different flaviviruses impair the type I IFN signaling pathway.

Section snippets

Innate immune sensing of flaviviruses

As suggested by Isaacs and Lindenmann's seminal studies, today we know that type I IFN is produced by infected cells upon sensing of conserved “non-self” signatures, also known as pathogen-associated molecular patterns (PAMPs), by specific host PRRs (reviewed in Refs. [18], [19], [20], [21]).

Depending on their subcellular localization, PRRs can be classified in two main categories. The first category includes the membrane bound Toll-like receptors (TLRs), TLR3, TLR7, TLR8 and TLR9, that are

Antagonism of type I IFN production

As eukaryotic cells have evolved several mechanisms to distinguish self from non-self nucleic acids, flaviviruses, like many other viruses, have developed different strategies to escape, or at least delay, innate immune recognition. Indeed, flaviviruses have been shown to be either weak inducers of type I IFN [62], [63], [64], or late-in-infection inducers, allowing a replicative advantage to the virus during the early replication stages [31]. A summary of the strategies used by different

Antagonism of type I IFN signaling

As mentioned above, type I IFN plays an essential role for the control of viral infection. To date, several studies have shown that pretreatment with type I IFN can inhibit flavivirus replication in vitro, and it is important to control viral replication and spread in vivo. Specifically, mouse strains that are deficient in the type I IFN receptor, or in key components of the IFN signaling pathway such as STAT1 and STAT2, show enhanced lethality and viral replication upon infection with WNV [100]

Type I IFN as a determinant of host tropism

Mice are naturally resistant to infection with flaviviruses. However, as mentioned above, mouse strains that are deficient in key antiviral signaling pathways are highly susceptible to flavivirus infection. This restriction can be at least in part explained by the fact that many flaviviruses cannot efficiently block type I IFN induction and/or signaling in mice [36], [37], [103], [122]. In this regard, we and others have observed that while the DENV NS2B3 protease is able to bind and cleave

Summary and outlook

As summarized above, flaviviruses invest a big part of their genome to counteract both IFN induction and effector pathways, and establish a successful infection in humans. This emphasizes the importance of bypassing the early type I IFN response for effective viral replication. To date, the NS5 proteins of several flaviviruses have emerged as the most potent active antagonists of type I IFN signaling. However, the mechanisms of NS5 inhibition are different among flavivirus species, suggesting

Acknowledgements

We thank all past and present members of the Fernandez-Sesma and García-Sastre laboratories for their precious contribution to several of the studies discussed in this review. We apologize to all colleagues whose important work could not be cited due to space constraints. Current flavivirus research in the García-Sastre laboratory is supported by the NIH/NIAID grant U19AI118610. Flavivirus research in the Fernandez-Sesma laboratory discussed in this review has been supported by the NIH/NIAID

List of abbreviations

2′-O-MTase
2′-O-methyltransferase
CARD
caspase activation and recruitment domain
cGAS
cyclic GMP-AMP synthase
cGMP-AMP
cyclic-di-GMP-AMP
DAMP
danger associated molecular pattern
DENV
dengue virus
dsRNAs
double-stranded RNA
ER
endoplasmic reticulum
gRNA
genomic RNA
IFIT
interferon induced protein with tetratricopeptide repeats
IFNAR
interferon receptor
IFNs
type I interferons
IkBα
NFKB inhibitor alpha
IKKε
inhibitor of kappa-B kinase epsilon
IRF3
interferon regulatory factor 3
IRF9
interferon regulatory factor 9
ISGF3
ISG

References (132)

  • X. Cai et al.

    The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling

    Mol. Cell

    (2014)
  • C.M. Cleary et al.

    Knockout and reconstitution of a functional human type I interferon receptor complex

    J. Biol. Chem.

    (1994)
  • D. Novick et al.

    The human interferon alpha/beta receptor: characterization and molecular cloning

    Cell

    (1994)
  • G.R. Stark et al.

    The JAK-STAT pathway at twenty

    Immunity

    (2012)
  • J.W. Schoggins

    Interferon-stimulated genes: roles in viral pathogenesis

    Curr. Opin. Virol.

    (2014)
  • A.C. Greenlund et al.

    Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process

    Immunity

    (1995)
  • K. Shuai et al.

    Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions

    Cell

    (1994)
  • J.L. Hyde et al.

    Innate immune restriction and antagonism of viral RNA lacking 2-O methylation

    Virology

    (2015)
  • A.L. Brass et al.

    The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus

    Cell

    (2009)
  • P. Sun et al.

    Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus

    Virology

    (2009)
  • P.D. Uchil et al.

    Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments

    J. Biol. Chem.

    (2003)
  • L. Miorin et al.

    Visual detection of Flavivirus RNA in living cells

    Methods

    (2016)
  • C. Chiang et al.

    Post-translational control of intracellular pathogen sensing pathways

    Trends Immunol.

    (2017)
  • M.U. Gack et al.

    Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I

    Cell Host Microbe

    (2009)
  • G.A. Versteeg et al.

    The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors

    Immunity

    (2013)
  • R. Rajsbaum et al.

    TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity

    J. Mol. Biol.

    (2014)
  • G.A. Versteeg et al.

    InTRIMsic immunity: positive and negative regulation of immune signaling by tripartite motif proteins

    Cytokine Growth Factor Rev.

    (2014)
  • G.P. Pijlman et al.

    A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity

    Cell Host Microbe

    (2008)
  • H.M. Liu et al.

    The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity

    Cell Host Microbe

    (2012)
  • N.C. Elde et al.

    The evolutionary conundrum of pathogen mimicry

    Nat. Rev. Microbiol.

    (2009)
  • A. Garcia-Sastre et al.

    Type 1 interferons and the virus-host relationship: a lesson in detente

    Science

    (2006)
  • A. Isaacs et al.

    Virus interference. I. The interferon

    Proc. R. Soc. Lond B Biol. Sci.

    (1957)
  • A. Isaacs et al.

    Virus interference. II. Some properties of interferon

    Proc. R. Soc. Lond B Biol. Sci.

    (1957)
  • A. Isaacs et al.

    Duration of protective action of interferon against infection with West Nile virus

    Nature

    (1959)
  • J.S. Mackenzie et al.

    Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

    Nat. Med.

    (2004)
  • D.R. Smith

    Waiting in the wings: the potential of mosquito transmitted flaviviruses to emerge

    Crit. Rev. Microbiol.

    (2016)
  • D. Paul et al.

    Flaviviridae replication organelles: oh, what a tangled web we weave

    Annu. Rev. Virol.

    (2015)
  • J.A. den Boon et al.

    Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories

    Annu. Rev. Microbiol.

    (2010)
  • I. Romero-Brey et al.

    Membranous replication factories induced by plus-strand RNA viruses

    Viruses

    (2014)
  • L. Miorin et al.

    Three-dimensional architecture of tick-borne encephalitis virus replication sites and trafficking of the replicated RNA

    J. Virol.

    (2013)
  • A.K. Overby et al.

    Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles

    J. Virol.

    (2010)
  • G.N. Barber

    Cytoplasmic DNA innate immune pathways

    Immunol. Rev.

    (2011)
  • A. Iwasaki

    A virological view of innate immune recognition

    Annu. Rev. Microbiol.

    (2012)
  • J. Wu et al.

    Innate immune sensing and signaling of cytosolic nucleic acids

    Annu. Rev. Immunol.

    (2014)
  • S. Akira

    TLR signaling

    Curr. Top. Microbiol. Immunol.

    (2006)
  • H. Kato et al.

    RIG-I-like receptors: cytoplasmic sensors for non-self RNA

    Immunol. Rev.

    (2011)
  • H. Kato et al.

    Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

    Nature

    (2006)
  • B.L. Fredericksen et al.

    Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1

    J. Virol.

    (2008)
  • Y.M. Loo et al.

    Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity

    J. Virol.

    (2008)
  • B.L. Fredericksen et al.

    West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling

    J. Virol.

    (2006)
  • Cited by (56)

    View all citing articles on Scopus
    1

    Co-First authors.

    View full text